We only have this paper's title and publication details.
Read it at the sourceExperimental study demonstrates an improved synthetic process for modified guanosine precursors, suggesting enhanced manufacturing routes for second-generation antisense oligonucleotides.
For Abstract see ChemInform Abstract in Full Text.
No takes yet. Share an insight, caveat, or question.
Taj et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: